GH
Income statement / Annual
Last year (2024), Guardant Health, Inc.'s total revenue was $739.02 M,
an increase of 31.04% from the previous year.
In 2024, Guardant Health, Inc.'s net income was -$436.37 M.
See Guardant Health, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$739.02 M |
$563.95 M |
$449.54 M |
$373.65 M |
$286.73 M |
$214.38 M |
$90.64 M |
$49.84 M |
$25.25 M |
| Cost of Revenue |
$289.80 M
|
$227.05 M
|
$156.33 M
|
$122.91 M
|
$92.54 M
|
$70.72 M
|
$43.21 M
|
$31.62 M
|
$22.12 M
|
| Gross Profit |
$449.22 M
|
$336.90 M
|
$293.21 M
|
$250.74 M
|
$194.20 M
|
$143.66 M
|
$47.43 M
|
$18.22 M
|
$3.13 M
|
| Gross Profit Ratio |
0.61
|
0.6
|
0.65
|
0.67
|
0.68
|
0.67
|
0.52
|
0.37
|
0.12
|
| Research and Development Expenses |
$347.75 M
|
$367.19 M
|
$373.81 M
|
$263.22 M
|
$149.86 M
|
$86.29 M
|
$50.71 M
|
$25.56 M
|
$10.86 M
|
| General & Administrative Expenses |
$180.12 M
|
$155.80 M
|
$163.96 M
|
$206.64 M
|
$192.77 M
|
$61.40 M
|
$36.19 M
|
$36.78 M
|
$9.92 M
|
| Selling & Marketing Expenses |
$364.94 M
|
$295.23 M
|
$299.83 M
|
$191.88 M
|
$106.51 M
|
$78.34 M
|
$53.47 M
|
$32.50 M
|
$26.19 M
|
| Selling, General & Administrative Expenses |
$545.06 M
|
$451.03 M
|
$463.78 M
|
$398.52 M
|
$299.28 M
|
$139.73 M
|
$89.66 M
|
$69.27 M
|
$36.11 M
|
| Other Expenses |
$0.00
|
$83.40 M
|
$0.00
|
$0.00
|
$0.00
|
$88.00 K
|
$0.00
|
$0.00
|
-$1.00 K
|
| Operating Expenses |
$892.81 M
|
$901.62 M
|
$837.59 M
|
$661.74 M
|
$449.15 M
|
$226.03 M
|
$140.37 M
|
$94.84 M
|
$46.97 M
|
| Cost And Expenses |
$1.18 B
|
$1.13 B
|
$993.92 M
|
$784.65 M
|
$541.68 M
|
$296.75 M
|
$183.58 M
|
$126.45 M
|
$69.10 M
|
| Interest Income |
$53.69 M
|
$35.37 M
|
$6.07 M
|
$3.93 M
|
$10.17 M
|
$13.74 M
|
$5.27 M
|
$2.23 M
|
$733.00 K
|
| Interest Expense |
$2.58 M
|
$2.58 M
|
$2.58 M
|
$2.58 M
|
$4.77 M
|
$1.18 M
|
$1.25 M
|
$2.70 M
|
$3.02 M
|
| Depreciation & Amortization |
$42.39 M
|
$42.88 M
|
$35.96 M
|
$22.27 M
|
$16.07 M
|
$13.61 M
|
$7.14 M
|
$5.21 M
|
$3.69 M
|
| EBITDA |
-$390.12 M |
-$433.31 M |
-$614.91 M |
-$359.62 M |
-$225.07 M |
-$54.93 M |
-$75.84 M |
-$75.31 M |
-$39.42 M |
| EBITDA Ratio |
-0.53
|
-0.77
|
-1.37
|
-0.96
|
-0.78
|
-0.26
|
-0.84
|
-1.51
|
-1.56
|
| Operating Income Ratio |
-0.6
|
-1
|
-1.21
|
-1.1
|
-0.89
|
-0.38
|
-1.03
|
-1.54
|
-1.74
|
| Total Other Income/Expenses Net |
$8.51 M
|
$85.96 M
|
-$109.07 M
|
$26.53 M
|
$9.05 M
|
$12.65 M
|
$8.72 M
|
-$6.60 M
|
-$2.29 M
|
| Income Before Tax |
-$435.09 M
|
-$478.76 M
|
-$653.45 M
|
-$384.47 M
|
-$245.90 M
|
-$69.72 M
|
-$84.23 M
|
-$83.21 M
|
-$46.13 M
|
| Income Before Tax Ratio |
-0.59
|
-0.85
|
-1.45
|
-1.03
|
-0.86
|
-0.33
|
-0.93
|
-1.67
|
-1.83
|
| Income Tax Expense |
$1.28 M
|
$685.00 K
|
$1.14 M
|
$300.00 K
|
$379.00 K
|
-$1.87 M
|
$38.00 K
|
$7.00 K
|
$6.00 K
|
| Net Income |
-$436.37 M
|
-$479.45 M
|
-$654.59 M
|
-$405.67 M
|
-$253.78 M
|
-$75.65 M
|
-$85.06 M
|
-$83.22 M
|
-$46.14 M
|
| Net Income Ratio |
-0.59
|
-0.85
|
-1.46
|
-1.09
|
-0.89
|
-0.35
|
-0.94
|
-1.67
|
-1.83
|
| EPS |
-3.56 |
-4.28 |
-6.41 |
-3.8 |
-2.53 |
-0.75 |
-1 |
-1.18 |
-3.49 |
| EPS Diluted |
-3.56 |
-4.28 |
-6.41 |
-3.8 |
-2.53 |
-0.75 |
-1 |
-1.18 |
-3.49 |
| Weighted Average Shares Out |
$122.75 M
|
$111.99 M
|
$102.18 M
|
$101.31 M
|
$97.50 M
|
$90.60 M
|
$85.03 M
|
$70.72 M
|
$13.22 M
|
| Weighted Average Shares Out Diluted |
$122.75 M
|
$111.99 M
|
$102.18 M
|
$101.31 M
|
$97.50 M
|
$90.60 M
|
$85.03 M
|
$70.72 M
|
$13.22 M
|
| Link |
|
|
|
|
|
|
|
|
|
